1186 related articles for article (PubMed ID: 15853987)
1. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
[TBL] [Abstract][Full Text] [Related]
3. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection.
Toan NL; Song le H; Kremsner PG; Duy DN; Binh VQ; Duechting A; Kaiser H; Torresi J; Kandolf R; Bock CT
J Hepatol; 2006 Sep; 45(3):361-9. PubMed ID: 16684578
[TBL] [Abstract][Full Text] [Related]
4. Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis.
Wang C; Heim A; Schlaphoff V; Suneetha PV; Stegmann KA; Jiang H; Krueger M; Fytili P; Schulz T; Cornberg M; Kandolf R; Manns MP; Bock CT; Wedemeyer H
J Med Virol; 2009 Dec; 81(12):2079-88. PubMed ID: 19856479
[TBL] [Abstract][Full Text] [Related]
5. Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis.
Kozireva SV; Zestkova JV; Mikazane HJ; Kadisa AL; Kakurina NA; Lejnieks AA; Danilane IN; Murovska MF
J Rheumatol; 2008 Jul; 35(7):1265-70. PubMed ID: 18484700
[TBL] [Abstract][Full Text] [Related]
6. Overt and hidden coinfection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda.
Stránský J; Malina L; Cieslarová B; Stríteský J; Půtová I; Horák J
Acta Virol; 2000 Feb; 44(1):23-8. PubMed ID: 10989688
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
[TBL] [Abstract][Full Text] [Related]
8. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
[TBL] [Abstract][Full Text] [Related]
9. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
Lehmann HW; Knöll A; Küster RM; Modrow S
Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
[TBL] [Abstract][Full Text] [Related]
10. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
11. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
Chu CM; Sheen IS; Liaw YF
Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
[TBL] [Abstract][Full Text] [Related]
12. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
[TBL] [Abstract][Full Text] [Related]
13. Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study.
Varache S; Narbonne V; Jousse-Joulin S; Guennoc X; Dougados M; Daurès JP; Devauchelle-Pensec V; Saraux A
Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1565-70. PubMed ID: 21954118
[TBL] [Abstract][Full Text] [Related]
14. [The prevalence of hepatitis G virus in patients with hepatitis B and C virus infections].
Kaya S; Cicioğlu Aridoğan B; Demirci M
Mikrobiyol Bul; 2004 Oct; 38(4):421-7. PubMed ID: 15700668
[TBL] [Abstract][Full Text] [Related]
15. Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19-correlated diseases.
Gallinella G; Zuffi E; Gentilomi G; Manaresi E; Venturoli S; Bonvicini F; Cricca M; Zerbini M; Musiani M
J Med Virol; 2003 Sep; 71(1):135-9. PubMed ID: 12858419
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver disease.
Fujiwara K; Tanaka Y; Orito E; Ohno T; Kato T; Sugauchi F; Suzuki S; Hattori Y; Sakurai M; Hasegawa I; Ozasa T; Kanie F; Kano H; Ueda R; Mizokami M
J Gastroenterol Hepatol; 2004 Dec; 19(12):1343-7. PubMed ID: 15610306
[TBL] [Abstract][Full Text] [Related]
17. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
18. [Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].
Uslu H; Kiki I; Ozbek A; Erdem F; Ayyildiz A
Mikrobiyol Bul; 2007 Oct; 41(4):597-602. PubMed ID: 18173080
[TBL] [Abstract][Full Text] [Related]
19. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis.
Sagnelli E; Coppola N; Scolastico C; Filippini P; Santantonio T; Stroffolini T; Piccinino F
Hepatology; 2000 Nov; 32(5):1106-10. PubMed ID: 11050062
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
Braham S; Gandhi J; Beard S; Cohen B
J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
